ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1872

The Effect of EEG-Amygdala-Related-Neurofeedback on REM Latency in Patients with Fibromyalgia

Noam Goldwway1, Haggai Sharon1, Eti Ben Simon1, Libat Weizman1, Ayam Greental1, Omer Lubin1, Marc Cavazza2, Fred Charles3, Talma Hendler1 and Jacob N. Ablin4, 1Functional Brain Center, Wohl Institute for Advanced Imaging, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel, 2School of Computing, Teesside University, United Kingdom, Middlesbrough, United Kingdom, 3Department of Creative Technology, Bournemouth University, Bournemouth, United Kingdom, 4Rheumatology, Rheumatology Institute, Tel Aviv, Tel Aviv, Israel

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fibromyalgia, neuroimaging and sleep

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Fibromyalgia syndrome (FMS) is a condition characterized by widespread pain, sleep disturbance and chronic fatigue, and mood disorder .FMS was suggested to represent a prototype of central nervous system hypersensitivity (central sensitivity-CS). While the mechanisms underlying CS remain incompletely understood, a role for limbic and sleep related dysregulation has been argued. The aim of the current study was to examine the feasibility of fMRI-inspired Electrical Finger Print (EFP) of the amygdala as a probe for NeuroFeedback (amyg-EFP NF) training for FM patients. We expected to find improved sleep quality among trainees successful in downregulating amygdala activity.

Methods:

Thirty four FMS patients (3M:31F, average age 35.6 SD=11.82) underwent 10 sessions of amyEFP-NF, targeting down-regulation of the amygdala. Nine patients received rewarding sham NF and served as a control group. The 24 patients that received real feedback were divided into successful (succ+) (N=13) and unsuccessful (succ-) (N=12) feedback learners. Two interfaces were used to give the feedback: Auditory feedback and multi-modal virtual reality feedback. An objective outcome measure of sleep quality was taken using the WatchPAT device before and after NF training

Results: Repeated measures ANOVA for feedback learning provided significant results (F=3.23 p=0.05), indicating that succ+ subjects displayed improved ability to regulate their amyEFP signal following treatment, in comparison to succ- and sham participants. The three groups also differed in REM latency improvement: repeated measures ANOVA for REM latency was significant (F=3.557 p=0.04), indicating that only succ+ subjects displayed longer REM latency following amyEFP-NF. Furthermore, the change in REM latency was correlated with feedback learning only in the succ+ group (R=0.497 p=0.05)

Conclusion:

In order to improve the sleep quality of patients suffering from central sensitivity disorder we targeted the amygdala, a limbic hub that is known to be affected by sleep impairment. We show feedback-specific effect of improved REM latency, a well-known marker for mood disorder. This study provides novel evidence of neurofeedback specific effect on objective sleep measures in FMS patients.


Disclosure: N. Goldwway, None; H. Sharon, None; E. Ben Simon, None; L. Weizman, None; A. Greental, None; O. Lubin, None; M. Cavazza, None; F. Charles, None; T. Hendler, None; J. N. Ablin, None.

To cite this abstract in AMA style:

Goldwway N, Sharon H, Ben Simon E, Weizman L, Greental A, Lubin O, Cavazza M, Charles F, Hendler T, Ablin JN. The Effect of EEG-Amygdala-Related-Neurofeedback on REM Latency in Patients with Fibromyalgia [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-effect-of-eeg-amygdala-related-neurofeedback-on-rem-latency-in-patients-with-fibromyalgia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-eeg-amygdala-related-neurofeedback-on-rem-latency-in-patients-with-fibromyalgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology